The stability of tryptophan metabolites prior to urine analysis

The stability of tryptophan metabolites prior to urine analysis

247 Clinica Chimica Acta, 102 (1980) 247-251 0 Elsevier/North-Holland Biomedical Press SHORT COMMUNICATION CCA 1299 THE STABILITY ANALYSIS F. GEER...

285KB Sizes 8 Downloads 35 Views

247

Clinica Chimica Acta, 102 (1980) 247-251 0 Elsevier/North-Holland Biomedical Press

SHORT COMMUNICATION CCA 1299

THE STABILITY ANALYSIS

F. GEERAERTS

OF TRYPTOPHAN

*, L. SCHIMPFESSEL

METABOLITES

and R. CROKAERT

Laboratorium voor Biochemie, Vrije Uniuersiteit Brussel, Farmacie, Laarbeeklaan 103, B-l 090 Brussels (Belgium) (Received

July 30th,

PRIOR TO URINE

Fakulteit

Geneeskunde

en

1979)

Summary A method for the quantitative preservation of tryptophan metabolites is described. Analysis of the samples was done by reversed phase HPLC. Results both for a standard solution and biological samples (urine are presented.

Introduction Tryptophan metabolism has been extensively studied by measuring the urinary excretion of its metabolites before and after tryptophan loading tests and in several pathological conditions. Using reversed-phase liquid chromatography coupled to ultraviolet and fluorescence detectors, the tryptophan metabolites can be separated quickly. However, the routine application of this analysis in clinical chemistry is retarded by the problems caused by the instability of the metabolites, especially in a mixture as complex as urine. Until now, little attention was paid to the storage conditions of the sample and their effects on the compounds under investigation. As changes in urine samples occur [1,2], the stability of tryptophan and six of its metabolites has been checked under different conditions of pH and temperature, using a mixture of standards, human and rat urine. The metabolites chosen are representative for the two main metabolic pathways of tryptophan.

* To whom correspondence

should be addressed.

248

Materials and methods The standard solution contained tryptophan (TRP) (Difco Lab., Detroit, U.S.A.); serotonin (SER) and 5-hydroxyt~ptophan (5-HTRP) (Fluka, Buchs, Switzerland); 5-hydroxyindoleacetic acid (5-HIAA) (Merck, Darmstadt, F.R.G.); indolelactic acid (ILA), kynurenine (KYN) and kynurenic acid (KYNA) (Sigma Chem. Comp., St. Louis, U.S.A.). The samples were stored both at pH 5.6 in a 0.2 mol/l phosphate buffer and pH 2, at room temperature (ta), 4°C and -18°C for a maximuln of 168 h. HCl (12 mol/l) was used for acidification. The solutions were analysed every 24 h by high performance reversed-phase chromatography on two ii-Bondapak C-18 colmmns in series (Waters Ass., Milford, U.S.A.), with an eluent system described by Sentfleber et al. [3] and Veening (personal communication). The low concentration eluent was a 0.025 mol/l sodium acetate buffer, pH 4.4, and the high concentration eluent a 0.1 mol/l acetic acid solution in methanol. The eluents were degassed with a water-vacuum line before use. The flow rate was 40 ml/h (corresponding to a linear velocity of 0.117 cm/s) and the temperature was ambient. The compounds were detected at 260 nm with a variable wavelength l_J.V.-detector (Model LC 55, Perkin-Elmer, Oakbrook, U.S.A.) and by native fluorescence (Fluorimeter 2000, Perkin Elmer} (excitation wavelength, 280 nm; emission wavelength, 360 nm). The peaks were quantified by measuring the peak area on the chromatogram by the height times width at half-height method. Results (a) Standard

solution

The reversed-phase HPLC separation of the seven components of the mixture is shown in Fig. 1. In the conditions used, kynurenine does not show any natural fluorescence. The peaks were identified by retention times, co-chromatography, U.V.-, and if possible, fluorescence spectra. The results of the stability study of the standard are summarized in Table I. At pH 5.6 and at ta, the compounds were stable for 48 h, except for kynurenic acid. Under these conditions this metabolite can only be stored for a maximum of 36 h, but 5-HIAA and ILA are stable during the whole period. Lowering the temperature to 4°C assures good stability of the sample solutes for at least 168 h, except for serotonin for which a loss of 20% is found if stored longer than 48 h. Similar results are obtained at -18°C but with even a greater loss of SER. The acidified samples (pH 2) are seen to be more stable than the corresponding original ones, especially at the lower temperatures. At t,, the KYN concentration decreases by 50% if stored for 168 h, 72 h beinb the maximum time for which this compound can be stored under these conditions without loss. TRP can be stored for 120 h, after 168 h of storage at pH 2 and at ta, there is a loss of nearly 40%. At -18”C, there is a small loss of 5-HIAA (15%) if stored longer than 144 h, but under these conditions, all other compounds were stable for at least 168 h. However, the best results were obtained with acidification at pH 2 and storage at 4°C. With this method, all the tryptophan metabolites tested were preserved for at least eight days.

249

A

FI

‘S

;20

I/

1 ...-_-..~~_ , ~.

KYN

~_

L__-.==_h G

Fig.

10

20

1. Reversed-phase

0.21

mmol/l;

0.17

mmol/I;

ple volume,

HPLC

SER.

0.10

ILA.

0.23

100

30

40

separation

mmol/l;

of

5-HTRP.

mmol/l.

For

~1. Fluorescence

50

the

0.23

standard

mmol/l;

abbreviations

scale

60

solution.

TRP,

used

is in arbitrary

7o

and

0.19

MIN



Composition mmol/l;

conditions.

of

KYNA,

the

0.33

see Materials

mixture: mmol/l;

and

KYN, 5-HIAA,

methods.

Sam-

units.

(b) Urine samples Fig. 2 shows the chromatogram obtained from a human urine spiked with the tryptophan metabolites under investigation. Additional fluorescent peaks are indican (IND) and unknowns (U). The preservation method giving the best results for the standard solution has been applied to human and rat urine samples (Table II). For both biological samples, pH 2, combined with a temper-

TABLE

I

COMPARISON

OF

STANDARDS (Percentage which

the

Compound

THE

UNDER of

peak

compound

STABILITY

OF

DIFFERENT area

STORAGE

remaining

is stable

% of control

under

after

168

the given

(control

TRYPTOPHAN

IN

A

SOLUTION

hours

of

storage.

Between

brackets,

the

time

50(48

h)

90

SER

70(72

h)

80(48

5-HTRP

70(48

h)

95

TRP

80(48

h)

100

85(36

h)

100

-18’C

tR

100 h)

70(48 95 100 95

50(72 h)

h)

4Oc

-18’C

100

100

90

100

90

95

95

60(120

h)

95

100

100 100

100

100

5-HIAA

100

100

100

100

100

85(144

ILA

100

100

100

100

100

95

temperature,

h)

= 100%)

4Oc

KYN

room

(in

PH 2

tR

tR,

OF

condition.)

PH 5.6

KYNA

METABOLITES

CONDITIONS

h)

for

250

t .L lV.abs.

~

Fig.

2.

tions.

Chromatogram see Materials

of

spiked

and methods.

human

urine.

Sample

volume,

IND, 100

indican;

U, unknown:

~1. Fluorescence

other

scale

abbreviations

is in arbitrary

and

corldi-

units.

ature of 4°C preserved the tryptophan metabolites for at least eight days, confirming and extending the results obtained for the standard solution. Discussion Preliminary attempts to work out a preservation method for all urinary U.V.absorbing compounds having failed [2], attention was focused on tryptophan and some of its urinary metabolites. The preservation of whole urine rather than extracts was tried as the tryptophan metabolites belong to different classes of chemical compounds so that the quantitative extraction of all products of interest is difficult to achieve. The results obtained at pH 2, 4°C and pH 2, -18°C are quite similar, but the

TABLE

II

STABILITY

OF

TRYPTOPHAN

(Conditions.

pH

2; temperature,

Compound

METABOLITES 4’C;

% of control Human

urine

IN

percentage

(control

URINE

of peak

= 100%) Rat

KYN

100

SER

95

100 95

5-HTRP

95

95

TRP

100

100

KYNA

100

100

5-HIAA

100

100

ILA

100

95

urine

SAMPLES

area remaining

after

168

hours

of storage.)

251

loss of 15% of 5-HIAA in the latter makes the former the method of choice. The method described guarantees a quantitative preservation of the metabolites tested prior to rapid chromatographic separation. Acknowledgement This work was supported by Grant 3.0016.75 kundig en Wetenschappelijk Onderzoek”.

of the “Fonds

voor Genees-

References 1

Grushka,

2

Geeraerts,

3

Sentfleber,

E.,

Kikta,

F..

Jr., E.J.

Schimpfessel,

F.C..

HaIIine,

and

Naylor,

L. and A.G.,

E.W.

Crokaert,

Veening,

(1977) R.

H. and

J. Chromatogr.

(1979) Dayton,

Arch. D.A.

Int.

143, Physiol.

(1976)

Clin.

5146 Biochem. Chem.

87, 22.

177-178

1522-1527